A classification of dayside auroral forms and activities as a function of interplanetary magnetic field orientation by Sandholt, Per Even, Farrugia, Charles J., Moen, Jøran, Noraberg, Øystein, Lybekk, Bjørn, Sten, Torleif, Hansen, Truls

Get full text

A classification of dayside auroral forms and activities as a function of interplanetary magnetic field orientation by Sandholt, Per E, Noraberg, Oystein, Lybekk, Bjorn, Sten, Torleif, Farrugia, Charles J, Moen, Joran, Hansen, Truls

Get full text

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomi... by Syversen, Silje Watterdal, Jørgensen, Kristin Kaasen, Goll, Guro Løvik, Brun, Marthe Kirkesæther, Sandanger, Øystein, Bjørlykke, Kristin Hammersbøen, Sexton, Joseph, Olsen, Inge Christoffer, Gehin, Johanna Elin, Warren, David John, Klaasen, Rolf Anton, Noraberg, Geir, Bruun, Trude Jannecke, Dotterud, Christian Kvikne, Ljoså, Maud Kristine Aga, Haugen, Anne Julsrud, Njålla, Rune Johan, Zettel, Camilla, Ystrøm, Carl Magnus, Bragnes, Yngvill Hovde, Skorpe, Svanaug, Thune, Turid, Seeberg, Kathrine Aglen, Michelsen, Brigitte, Blomgren, Ingrid Marianne, Strand, Eldri Kveine, Mielnik, Pawel, Torp, Roald, Mørk, Cato, Kvien, Tore K, Jahnsen, Jørgen, Bolstad, Nils, Haavardsholm, Espen A

Get full text

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomi... by Syversen, Silje Watterdal, Goll, Guro Løvik, Jørgensen, Kristin Kaasen, Sandanger, Øystein, Sexton, Joseph, Olsen, Inge Christoffer, Gehin, Johanna Elin, Warren, David John, Brun, Marthe Kirkesæther, Klaasen, Rolf Anton, Karlsen, Lars Normann, Noraberg, Geir, Zettel, Camilla, Ljoså, Maud Kristine Aga, Haugen, Anne Julsrud, Njålla, Rune Johan, Bruun, Trude Jannecke, Seeberg, Kathrine Aglen, Michelsen, Brigitte, Strand, Eldri Kveine, Skorpe, Svanaug, Blomgren, Ingrid Marianne, Bragnes, Yngvill Hovde, Dotterud, Christian Kvikne, Thune, Turid, Ystrøm, Carl Magnus, Torp, Roald, Mielnik, Pawel, Mørk, Cato, Kvien, Tore K, Jahnsen, Jørgen, Bolstad, Nils, Haavardsholm, Espen A

Get full text

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomi... by Syversen, Silje Watterdal, Goll, Guro Løvik, Jørgensen, Kristin Kaasen, Sandanger, Øystein, Sexton, Joseph, Olsen, Inge Christoffer, Gehin, Johanna Elin, Warren, David, Brun, Marthe Kirkesæther, Klaasen, Rolf, Karlsen, Lars Normann, Noraberg, Geir, Zettel, Camilla, Ljoså, Maud-Kristine Aga, Haugen, Anne Julsrud, Njålla, Rune Johan, Bruun, Trude J, Seeberg, Kathrine, Michelsen, Brigitte, Strand, Eldri Kveine, Skorpe, Svanaug, Blomgren, Ingrid, Bragnes, Yngvill, Dotterud, Christian, Thune, Turid Jorunn, Ystrøm, Carl Magnus, Torp, Roald, Pawel, Mielnik, Mørk, Cato, Kvien, Tore Kristian, Jahnsen, Jørgen, Bolstad, Nils, Haavardsholm, Espen A

Request full text

Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: Open‐label extension of the NOR‐SWITCH trial by Goll, Guro Løvik, Jørgensen, Kristin Kaasen, Sexton, Joseph, Olsen, Inge Christoffer, Bolstad, Nils, Haavardsholm, Espen A, Lundin, Knut Erik Aslaksen, Tveit, Kåre Steinar, Lorentzen, Merete, Berset, Ingrid Prytz, Fevang, Bjørg-Tilde Svanes, Kalstad, Synnøve, Ryggen, Kristin, Warren, David, Klaasen, Rolf, Asak, Øivind Wessel, Baigh, Somyeh, Blomgren, Ingrid, Brenna, Øystein, Bruun, Trude J, Dvergsnes, Katrine, Frigstad, Svein Oskar, Myrnes, Inger, Hatten, Ingvild Helgheim, Huppertz-Hauss, Gert, Henriksen, Magne, Hoie, Sunniva S, Krogh, Jan Reidar, Midtgard, Irina P, Mielnik, Pawel, Moum, Bjørn, Noraberg, Geir, Poyan, Armin, Prestegård, Ulf, Rashid, Haroon Ur, Strand, Eldri Kveine, Skjetne, Kristine, Seeberg, Kathrine, Torp, Roald, Ystrøm, Carl Magnus, Vold, Cecilia, Zettel, Camilla C, Waksvik, Kenneth, Gulbrandsen, Bjørn, Hagfors, Jon, Mørk, Cato, Jahnsen, Jørgen, Kvien, Tore Kristian

Request full text

Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: Open‐label extension of the NOR‐SWITCH trial by Goll, Guro Løvik, Jørgensen, Kristin Kaasen, Sexton, Joseph, Olsen, Inge Christoffer, Bolstad, Nils, Haavardsholm, Espen A, Lundin, Knut Erik Aslaksen, Tveit, Kåre Steinar, Lorentzen, Merete, Berset, Ingrid Prytz, Fevang, Bjørg-Tilde Svanes, Kalstad, Synnøve, Ryggen, Kristin, Warren, David, Klaasen, Rolf, Asak, Øivind Wessel, Baigh, Somyeh, Blomgren, Ingrid, Brenna, Øystein, Bruun, Trude J, Dvergsnes, Katrine, Frigstad, Svein Oskar, Myrnes, Inger, Hatten, Ingvild Helgheim, Huppertz-Hauss, Gert, Henriksen, Magne, Hoie, Sunniva S, Krogh, Jan Reidar, Midtgard, Irina P, Mielnik, Pawel, Moum, Bjørn, Noraberg, Geir, Poyan, Armin, Prestegård, Ulf, Rashid, Haroon Ur, Strand, Eldri Kveine, Skjetne, Kristine, Seeberg, Kathrine, Torp, Roald, Ystrøm, Carl Magnus, Vold, Cecilia, Zettel, Camilla C, Waksvik, Kenneth, Gulbrandsen, Bjørn, Hagfors, Jon, Mørk, Cato, Jahnsen, Jørgen, Kvien, Tore Kristian

Request full text